TrialBone marrow transplantation2015

Risk model incorporating donor IL6 and IFNG genotype and gastrointestinal GVHD can discriminate patients at high risk of steroid refractory acute GVHD.

N Alam et al.PubMed ↗Publisher ↗

No numbers read from the abstract.